Arix Bioscience PLC
LSE:ARIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arix Bioscience PLC
LSE:ARIX
|
UK |
|
Avance Gas Holding Ltd
OSE:AGAS
|
BM |
|
Magnetic North Acquisition Corp
XTSX:MNC
|
CA |
|
C
|
Chakana Copper Corp
SWB:1ZX
|
CA |
|
Gongniu Group Co Ltd
SSE:603195
|
CN |
|
D
|
DI Corp
KRX:003160
|
KR |
Arix Bioscience PLC
Arix Bioscience Plc is a global venture capital company. The firm is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. The firm's principal activity is to source, finance and develop healthcare and life science businesses across the world. The firm focuses on acquiring interests in, and provide operational oversight to, healthcare and life science businesses with which it partners in the healthcare and life science sector. The Company’s portfolio includes Harpoon Therapeutics, Inc. (HARP), Artios Pharma Ltd (Artios), Aura Biosciences Inc (Aura), LogicBio Therapeutics, Inc. (LOGC). The firm's subsidiaries include Depixus SAS (EUR), Quench Bio, Inc., Stipe Therapeutics Aps and Twelve Bio Aps.
Arix Bioscience Plc is a global venture capital company. The firm is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. The firm's principal activity is to source, finance and develop healthcare and life science businesses across the world. The firm focuses on acquiring interests in, and provide operational oversight to, healthcare and life science businesses with which it partners in the healthcare and life science sector. The Company’s portfolio includes Harpoon Therapeutics, Inc. (HARP), Artios Pharma Ltd (Artios), Aura Biosciences Inc (Aura), LogicBio Therapeutics, Inc. (LOGC). The firm's subsidiaries include Depixus SAS (EUR), Quench Bio, Inc., Stipe Therapeutics Aps and Twelve Bio Aps.
